A discussion reveals that prior to the COVID vaccines, there were no viable mRNA drugs on the market, highlighting the experimental nature of these vaccines. The conversation delves into the legal complexities surrounding their approval and the misleading communication to the public about their status. It raises critical questions about the transparency of information provided to society regarding these medical products.
